Gabrielle Fröberg

Publications
CV
Public outreach and news

Articles

Article: JOURNAL OF INFECTIOUS DISEASES. 2025;232(1):e78-e88
Improved Detection of Extrapulmonary and Paucibacillary Pulmonary Tuberculosis by Xpert MTB Host Response in a Tuberculosis Low-Endemic, High-Resource Setting
Folkesson E; Froberg G; Sundling C; Schon T; Sodersten E; Bruchfeld J
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2023;67(10):e0052823-e00523
The in vitro effecteffect of new combinations of carbapenem-ßlactamase inhibitors for MycobacteriumabscessusMycobacterium abscessus
Froberg G; Ahmed A; Chryssanthou E; Davies Forsman L
Article: CLINICAL MICROBIOLOGY AND INFECTION. 2023;29(6):758-764
Towards clinical breakpoints for non-tuberculous mycobacteria-Determination of epidemiological cut off values for the Mycobacterium avium complex and Mycobacterium abscessus using broth microdilution
Froberg G; Maurer FP; Chryssanthou E; Fernstrom L; Benmansour H; Boarbi S; Mengshoel AT; Keller PM; Viveiros M; Machado D; Fitzgibbon MM; Mok S; Werngren J; Cirillo DM; Alcaide F; Hyyrylainen H-L; Aubry A; Andres S; Nadarajan D; Svensson E; Turnidge J; Giske CG; Kahlmeter G; Cambau E; van Ingen J; Schon T
Article: JOURNAL OF INFECTIOUS DISEASES. 2023;227(6):820-827
A Rough Colony Morphology of Mycobacterium abscessus Is Associated With Cavitary Pulmonary Disease and Poor Clinical Outcome
Hedin W; Froberg G; Fredman K; Chryssanthou E; Selmeryd I; Gillman A; Orsini L; Runold M; Joensson B; Schon T; Forsman LD
Article: ISCIENCE. 2022;25(12):105652
A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis
Mousavian Z; Folkesson E; Froberg G; Foroogh F; Correia-Neves M; Bruchfeld J; Kallenius G; Sundling C
Article: FRONTIERS IN IMMUNOLOGY. 2021;12:727300
High Dimensional Immune Profiling Reveals Different Response Patterns in Active and Latent Tuberculosis Following Stimulation With Mycobacterial Glycolipids
Silva CS; Sundling C; Folkesson E; Froberg G; Nobrega C; Canto-Gomes J; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Kallenius G
Article: TUBERCULOSIS. 2020;123:101959
CD4⁺ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection
Borgstrom EW; Froberg G; Correia-Neves M; Atterfelt FB; Bellbrant J; Szulkin R; Chryssanthou E; Angeby K; Tecleab T; Ruhwald M; Andersen P; Kallenius G; Bruchfeld J
Article: EUROPEAN RESPIRATORY JOURNAL. 2020;55(3):1900851
Screening and treatment of tuberculosis among pregnant women in Stockholm, Sweden, 2016-2017
Froberg G; Jansson L; Nyberg K; Obasi B; Westling K; Berggren I; Bruchfeld J
Article: ERJ OPEN RESEARCH. 2019;5(2):78-2019
A new mathematical model to identify contacts with recent and remote latent tuberculosis
Froberg G; Borgstrom EW; Chryssanthou E; Correia-Neves M; Kallenius G; Bruchfeld J
Article: INFECTION GENETICS AND EVOLUTION. 2015;33:110-117
Characterising temporal trends in asymptomatic Plasmodium infections and transporter polymorphisms during transition from high to low transmission in Zanzibar, 2005-2013
Morris U; Xu W; Msellem MI; Schwartz A; Abass A; Shakely D; Cook J; Bhattarai A; Petzold M; Greenhouse B; Ali AS; Bjorkman A; Froberg G; Martensson A
Article: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2014;91(4):833-843
Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P-falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine
Venkatesan M; Gadalla NB; Stepniewska K; Dahal P; Nsanzabana C; Moriera C; Price RN; Martensson A; Rosenthal PJ; Dorsey G; Sutherland CJ; Guerin P; Davis TME; Menard D; Adam I; Ademowo G; Arze C; Baliraine FN; Berens-Riha N; Bjorkman A; Borrmann S; Checchi F; Desai M; Dhorda M; Djimde AA; El-Sayed BB; Eshetu T; Eyase F; Falade C; Faucher J-F; Froberg G; Grivoyannis A; Hamour S; Houze S; Johnson J; Kamugisha E; Kariuki S; Kiechel J-R; Kironde F; Kofoed P-E; LeBras J; Malmberg M; Mwai L; Ngasala B; Nosten F; Nsobya SL; Nzila A; Oguike M; Otienoburu SD; Ogutu B; Ouedraogo J-B; Piola P; Rombo L; Schramm B; Some AF; Thwing J; Ursing J; Wong RPM; Zeynudin A; Zongo I; Plowe CV; Sibley CH
Article: ANNALS OF INTERNAL MEDICINE. 2013;158(6):456-468
GeoSentinel Surveillance of Illness in Returned Travelers, 2007-2011
Leder K; Torresi J; Libman MD; Cramer JP; Castelli F; Schlagenhauf P; Wilder-Smith A; Wilson ME; Keystone JS; Schwartz E; Barnett ED; von Sonnenburg F; Brownstein JS; Cheng AC; Sotir MJ; Esposito DH; Freedman DO
Article: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 2013;57(2):887-892
Assessing the Cost-Benefit Effect of a Plasmodium falciparum Drug Resistance Mutation on Parasite Growth In Vitro
Froberg G; Ferreira PE; Martensson A; Ali A; Bjorkman A; Gil JP
Article: MALARIA JOURNAL. 2012;11:321
Decreased prevalence of Plasmodium falciparum resistance markers to amodiaquine despite its wide scale use as ACT partner drug in Zanzibar
Froberg G; Jornhagen L; Morris U; Shakely D; Msellem MI; Gil JP; Bjorkman A; Martensson A
Article: PLOS ONE. 2011;6(9):e23875
PfMDR1: Mechanisms of Transport Modulation by Functional Polymorphisms
Ferreira PE; Holmgren G; Veiga MI; Uhlen P; Kaneko A; Gil JP
Article: AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE. 2007;77(6):1034-1038
Short report:: Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to arnodiaquine and desethylarnodiaquine
Echeverry DF; Holmgren G; Murillo C; Higuita JC; Bjorkman A; Gil JP; Osorio L
Article: INFECTION GENETICS AND EVOLUTION. 2007;7(5):562-569
Selection of pfmdr1 mutations after amodiaquine monotherapy and amodiaquine plus artemisinin combination therapy in East Africa
Holmgren G; Hamrin J; Svard J; Martensson A; Gil JP; Bjorkman A
Article: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2006;11(12):1808-1812
Amodiaquine resistance is not related to rare findings of pfmdr1 gene amplifications in Kenya
Holmgren G; Bjorkman A; Gil JP
Article: INFECTION GENETICS AND EVOLUTION. 2006;6(4):309-314
Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y
Holmgren G; Gil JP; Ferreira PM; Veiga MI; Obonyo CO; Björkman A

All other publications

Letter: JOURNAL OF INFECTIOUS DISEASES. 2025;232(5):e860
Reply to Singh "An Ideal Point-of-Care Test for Screening TB Infection"
Folkesson E; Froberg G; Sundling C; Schon T; Sodersten E; Bruchfeld J
Review: INTERNATIONAL JOURNAL OF MYCOBACTERIOLOGY. 2023;12(3):211-225
The In vitro activity of carbapenems alone and in combination with β-lactamase inhibitors against difficult-to-treat mycobacteria; Mycobacterium tuberculosis, Mycobacterium abscessus, and Mycobacterium avium complex: A systematic review
Andersson V; Froberg G; Dahl V; Chryssanthou E; Giske C; Schon T; Forsman L
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2022;52:15
Network-based analysis reveals a plasma protein signature associated with active tuberculosis
Mousavian Z; Folkesson E; Froberg G; Foroogh F; Correia-Neves M; Goletti D; Bruchfeld J; Kallenius G; Sundling C
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2022;52:29
Individuals with active and latent Tuberculosis have distinct NK cell function
Silva CS; Folkesson E; Froberg G; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Correia-Neves M; Kallenius G; Sundling C
Preprint: MEDRXIV. 2022
A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis
Mousavian Z; Folkesson E; Fröberg G; Foroogh F; Correia-Neves M; Bruchfeld J; Källenius G; Sundling C
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2021;94(6)
Stimulation with mycobacterial glycolipids reveals different innate immune response profiles in active and latent Tuberculosis
Silva C; Sundling C; Folkesson E; Froberg G; Nobrega C; Canto--Gomes J; Chambers B; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Kallenius G
Conference publication: EUROPEAN JOURNAL OF IMMUNOLOGY. 2021;51:297
Stimulation with mycobacterial glycolipids reveals different innate immune response profiles in active and latent tuberculosis
Silva CS; Sundling C; Folkesson E; Froberg G; Nobrega C; Chambers BJ; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Neves MC; Kallenius G
Preprint: BIORXIV. 2021
Stimulation with mycobacterial glycolipids and PPD reveals different innate immune response profiles in active and latent TB
Silva C; Sundling C; Folkeson E; Fröberg G; Nobrega C; Canto-Gomes J; Chambers B; Lakshmikanth T; Brodin P; Bruchfeld J; Nigou J; Correia-Neves M; Källenius G
Book chapter: ESSENTIAL TUBERCULOSIS. 2021;p. 259-266
Extrapulmonary Tuberculosis
Bruchfeld J; Forsman LD; Fröberg G; Niward K
Review: ERJ OPEN RESEARCH. 2019;5(1):115-2018
Biomarkers for tuberculosis: the case for lipoarabinomannan
Correia-Neves M; Froberg G; Korshun L; Viegas S; Vaz P; Ramanlal N; Bruchfeld J; Hamasur B; Brennan P; Kallenius G
Letter: EUROPEAN RESPIRATORY JOURNAL. 2019;53(2):1801128
Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice
Froberg G; Jansson L; Bruchfeld J
Conference publication: TROPICAL MEDICINE & INTERNATIONAL HEALTH. 2015;20:185-186
How is Plasmodium falciparum parasite invitro growth fitness affected by drug resistance associated Pfcrt mutations?
Schmidt BA; Bjorkman A; Froberg G
Letter: JOURNAL OF INFECTIOUS DISEASES. 2013;207(4):687-688
CYP2C8 Status of Patients With Malaria Influences Selection of Plasmodium falciparum pfmdr1 Alleles After Amodiaquine-Artesunate Treatment
Cavaco I; Martensson A; Froberg G; Msellem M; Bjorkman A; Gil JP
Doctoral thesis: 2010
Plasmodium falciparum resistance to amodiaquine in monotherapy and in combination therapy with artesunate
Holmgren G

Articles

All other publications

Employments

Degrees and Education

News from KI

Events from KI